B A C Dijkmans
Overview
Explore the profile of B A C Dijkmans including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
5292
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van Sijl A, van den Oever I, Peters M, Boers M, Dijkmans B, van Halm V, et al.
Ann Rheum Dis
. 2011 Sep;
71(3):341-4.
PMID: 21953344
Background: Patients with rheumatoid arthritis (RA) have double the risk of cardiovascular (CV) disease, largely independently of traditional CV risk factors. Renal dysfunction is associated with CV morbidity and mortality...
12.
van der Weijden M, van der Horst-Bruinsma I, van Denderen J, Dijkmans B, Heymans M, Lems W
Osteoporos Int
. 2011 Sep;
23(6):1683-90.
PMID: 21927925
Unlabelled: We demonstrated that vertebral fractures (VF) are commonly found in early SpA. Patients with VF had lower lumbar BMD than patients without VF. VF remained frequently 'unrecognized' and untreated....
13.
Dirven L, Guler-Yuksel M, de Beus W, Ronday H, Speyer I, Huizinga T, et al.
Arthritis Care Res (Hoboken)
. 2011 Sep;
63(12):1691-9.
PMID: 21905248
Objective: To determine if metacarpal bone mineral density (mBMD) gain occurs in patients with rheumatoid arthritis (RA). If mBMD loss is driven by inflammation, we expect to find mBMD gain...
14.
Klarenbeek N, Koevoets R, van der Heijde D, Gerards A, Ten Wolde S, Kerstens P, et al.
Ann Rheum Dis
. 2011 Aug;
70(10):1815-21.
PMID: 21813548
Objective: To compare nine disease activity indices and the new American College of Rheumatology (ACR)/European League against Rheumatism (EULAR) remission criteria in rheumatoid arthritis (RA) and to relate these to...
15.
Koevoets R, Klarenbeek N, Guler-Yuksel M, van Oosterhout M, van Krugten M, Kerstens P, et al.
Ann Rheum Dis
. 2011 May;
70(8):1471-4.
PMID: 21551508
Objective: To evaluate three disease activity score (DAS) alternatives without the Ritchie articular index (RAI). To compare the use of patient global assessment (PGA) of disease activity versus global assessment...
16.
Gossec L, Paternotte S, Aanerud G, Balanescu A, Boumpas D, Carmona L, et al.
Ann Rheum Dis
. 2011 May;
70(6):935-42.
PMID: 21540201
Objective: A patient-derived composite measure of the impact of rheumatoid arthritis (RA), the rheumatoid arthritis impact of disease (RAID) score, takes into account pain, functional capacity, fatigue, physical and emotional...
17.
van den Broek M, Klarenbeek N, Dirven L, van Schaardenburg D, Hulsmans H, Kerstens P, et al.
Ann Rheum Dis
. 2011 Apr;
70(8):1389-94.
PMID: 21515916
Objective: To describe the disease course after the cessation of infliximab in early rheumatoid arthritis patients with disease activity score (DAS)-steered treatment and to identify predictors of persistent low disease...
18.
Korswagen L, Bartelds G, Krieckaert C, Turkstra F, Nurmohamed M, van Schaardenburg D, et al.
Arthritis Rheum
. 2011 Apr;
63(4):877-83.
PMID: 21452312
Objective: We observed 3 patients who developed severe venous and arterial thromboembolic events during treatment with adalimumab, 2 of whom had rheumatoid arthritis (RA) and 1 of whom had psoriatic...
19.
De Leest H, Steen K, Lems W, Van de Laar M, Huisman A, Kadir S, et al.
Eur J Clin Microbiol Infect Dis
. 2011 Feb;
30(7):903-8.
PMID: 21293900
The treatment of choice of H. pylori infections is a 7-day triple-therapy with a proton pump inhibitor (PPI) plus amoxicillin and either clarithromycin or metronidazole, depending on local antibiotic resistance...
20.
van de Sande M, de Hair M, van der Leij C, Klarenbeek P, Bos W, Smith M, et al.
Ann Rheum Dis
. 2010 Dec;
70(5):772-7.
PMID: 21177292
Background: The aetiology of rheumatoid arthritis (RA), a prototype immune-mediated inflammatory disorder, is poorly understood. It is currently unknown whether the disease process starts in the synovium, the primary target...